Bleeding control in open heart surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how to manage bleeding during and after open heart surgery. If you are having this type of surgery, the research may help improve blood loss control and your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be scheduled for open heart surgery (surgery on your heart that requires opening the chest).
- You must be willing and able to give your permission (informed consent) to take part in the study.
- Your surgery cannot be an emergency (needing to be done immediately).
- You must not have a known bleeding disorder or a tendency to bleed easily.
- You must not be on regular blood thinners (like warfarin or heparin) at the time of surgery.
- You must not have kidney failure that requires dialysis or an active cancer (malignancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special blood test called TEG can help doctors manage bleeding during major surgeries in children. It may help reduce the need for blood transfusions by guiding treatment more precisely.
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study tests a new blood test that measures how well your blood forms clots. It aims to see if this test can predict bleeding after heart surgery that uses a heart-lung machine, which might help doctors manage bleeding better.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
Hear when a new Open Heart Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.